Grabie M, Nussbaum P, Goldfarb S, Walker B R, Goldberg M, Agus Z S
Clin Pharmacol Ther. 1980 Apr;27(4):522-7. doi: 10.1038/clpt.1980.73.
To determine the effects of methyldopa on renal function, clearance studies were performed on hypertensive subjects during sustained steady-state water diuresis. The data reveal an acute fall in glomerular filtration rate and sodium clearance, whereas renal blood flow was unchanged. The antinatriuresis was the result of decreased filtration of sodium and possibly enhanced proximal tubular sodium reabsorption. These changes occurred before any demonstrable fall in systemic blood pressure; thus a direct effect of the drug on arteriolar resistance within the renal circulation is suggested. Chronic administration of methyldopa for 1 wk induced sustained reduction in blood pressure and resulted in the same changes in renal hemodynamics and sodium excretion noted after acute administration. These data suggest that methyldopa, like other antihypertensives, reduces glomerular filtration rate and increases sodium retention.
为了确定甲基多巴对肾功能的影响,在持续性稳态水利尿期间对高血压受试者进行了清除率研究。数据显示肾小球滤过率和钠清除率急剧下降,而肾血流量未变。钠潴留是由于钠滤过减少以及可能近端肾小管钠重吸收增强所致。这些变化发生在全身血压出现任何可证实的下降之前;因此提示该药物对肾循环中小动脉阻力有直接作用。甲基多巴连续给药1周可使血压持续降低,并导致与急性给药后相同的肾血流动力学和钠排泄变化。这些数据表明,甲基多巴与其他抗高血压药一样,会降低肾小球滤过率并增加钠潴留。